Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation
- 31 October 1996
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (4), 561-571
- https://doi.org/10.1016/s0272-6386(96)90468-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cisplatin-Associated hemolytic uremic syndromeCancer, 1994
- BENEFICIAL EFFECT OF ASPIRIN AND HEPARIN IN THREE-DAY DOG KIDNEY PRESERVATIONTransplantation, 1993
- EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1993
- Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factorKidney International, 1992
- Thrombotic microangiopathiesCritical Reviews in Oncology/Hematology, 1991
- Lack of Effect of the Calcium Antagonist Isradipine on Cyclosporine Pharmacokinetics in Renal Transplant PatientsTherapeutic Drug Monitoring, 1991
- Effects of Isradipine on Renal Function in Cydosporin-Treated Renal Transplanted PatientsNephrology Dialysis Transplantation, 1991
- IN VIVO FLUORESCENCE MICROSCOPY OF KIDNEY SUBCAPSULAR BLOOD FLOW IN MICE EFFECTS OF CYCLOSPORINE, (NVA)-CYCLOSPORINE, AND ISRADIPINE, A NEW CALCIUM ANTAGONISTTransplantation, 1988
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980